Optimization of an Experimental Vaccine To Prevent Escherichia

PDF) Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection

Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting - ScienceDirect

Vaccines, Free Full-Text

Current view on novel vaccine technologies to combat human infectious diseases

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Current status of experimental models for the study of malaria, Parasitology

Frontiers Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications

STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema

A Customized Bayesian Algorithm to Optimize Enzyme-Catalyzed Reactions

mRNA vaccines for COVID-19: what, why and how

Vaccines, Free Full-Text

Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice